Indeed, PPAT dysfunction and inflammation not only amplify rudimentary neoplastic alterations of the healthy prostate, but also promote PCa progression, metastasis, and resistance to chemotherapy [17,18,19,20,21,22]. This evidence concerns the gene PPAT and posterior cortical atrophy.